Wie hoch ist der Preis für Agile Therapeutics, Inc. (AGRX)

Preis für Agile Therapeutics, Inc. (AGRX) ist $1.51

Wie hoch ist die Marktkapitalisierung für Agile Therapeutics, Inc. (AGRX)

Marktkapitalisierung für Agile Therapeutics, Inc. (AGRX) ist $1.12M

Agile Therapeutics, Inc. (AGRX) Aktiensplits

Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.

Jahr	Aktien-Split	Multiplikator	Kumulierter Multiplikator
2023-04-11	1:50	x0.02	x0.0005
2022-04-27	1:40	x0.025	x0.025

Jahr

Aktien-Split

Multiplikator

Kumulierter Multiplikator

2023-04-11

1:50

x0.02

x0.0005

2022-04-27

1:40

x0.025

Unternehmen	Anzahl der Aktiensplits	Kumulierter Multiplikator	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	0	-	DE
Merck KGaA MRK.DE	0	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0	-	JP
Galderma Group AG GALD.SW	0	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5	x119	IN

Unternehmen

Anzahl der Aktiensplits

Kumulierter Multiplikator

Land